Thus, the present study aimed to characterize the phenotype of macrophages (CD45+HLA-DR+CD11b+CD14+) recovered from tumor samples from patients diagnosed with GBM and submitted to immunotherapy with dendritic cells, correlating their frequency and phenotype with the survival of these patients. This evidence concerns the gene ITGAM and glioblastoma.